Vasodilators Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

 

The vasodilators market consists of sales of tablets, capsules, injectable solutions, transdermal patches, oral solutions, sublingual tablets, intravenous infusions, topical creams, and gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Sizing and Forecast
The vasodilators market size has grown strongly in recent years. It will grow from $6.01 billion in 2023 to $6.40 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%.  The growth in the historic period can be attributed to increased awareness and diagnosis, government initiatives and healthcare policies, rising health awareness among the people, advancements in gene therapy, and increasing adoption of artificial intelligence.

The vasodilators market size is expected to see strong growth in the next few years. It will grow to $8.22 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.  The growth in the forecast period can be attributed to the rising prevalence of hypertension and cardiovascular diseases, growing demand for advanced medical technology for cardiac diseases, the increasing geriatric population worldwide, the rising prevalence of diabetes and high blood pressure, growing importance of personalized medicine. Major trends in the forecast period include strategic mergers and acquisitions, the shift towards outpatient settings and home-based care, product innovations, technological advancements, and expansion of healthcare infrastructure.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/vasodilators-global-market-report

Segmentation & Regional Insights
The vasodilators market covered in this report is segmented –
1) By Type: Arterial Dilators, Venous Dilators, Mixed Dilators
2) By Drugs: Nitroglycerin, Alprostadil, Minoxidil, Sorbitrate, Other Drugs
3) By Indication: Hypertension, Angina, Heart Failure, Other Indications
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End User: Hospitals, Homecare, Speciality Centres, Other End Users

North America was the largest region in the vasodilators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vasodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16565&type=smp

Major Driver Impacting Market Growth
The rising prevalence of cardiovascular diseases is expected to propel the growth of the vasodilators market going forward. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, and stroke, often linked to hypertension and other risk factors. The increasing prevalence of cardiovascular diseases is primarily driven by sedentary lifestyles, poor dietary habits, obesity, tobacco use, and aging populations. Vasodilators are used in cardiovascular diseases to relax blood vessels, reduce blood pressure, and improve blood flow. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based public agency, coronary artery disease (CAD) was responsible for killing 375,476 people in 2021, and about 1 in 20 adults age 20 and older had CAD. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the vasodilators market.

<h4 class=reporthtag>Sedentary Lifestyles Fuel Growth In The Vasodilator Market</h4>

The increased adoption of sedentary lifestyles is expected to propel the growth of the vasodilators market going forward. A sedentary lifestyle refers to limited physical activity and excessive time spent sitting or lying down, often associated with minimal exercise or movement. It is increasing due to modern conveniences such as technology, transportation, and desk-bound jobs, which promote prolonged periods of inactivity. The increased adoption of sedentary lifestyles is driven by technological advancements and modern work environments that prioritize convenience and prolonged sitting. In sedentary lifestyles, vasodilators can improve blood flow and reduce hypertension, mitigating cardiovascular risks. For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, new population data from 2022 indicate that 22 states have an adult obesity rate of 35% or higher, up from 19 states in 2021. Therefore, the increased adoption of sedentary lifestyles is driving the growth of the vasodilators market.

Key Industry Players
Major companies operating in the vasodilators market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc., Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc. , AstraZeneca, Mayo Foundation for Medical Education and Research (MFMER), Boehringer Ingelheim International GmbH, Bayer AG, Viatris Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen

The vasodilators market report table of contents includes:
1. Executive Summary

2. Vasodilators Market Characteristics

3. Vasodilators Market Trends And Strategies

4. Vasodilators Market - Macro Economic Scenario

5. Global Vasodilators Market Size and Growth

.
32. Global Vasodilators Market Competitive Benchmarking

33. Global Vasodilators Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Vasodilators Market

35. Vasodilators Market Future Outlook and Potential Analysis

36. Appendix

Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model